Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	3083.73	-749.12	23.53
Graham Fair Price	16.22	38.52	33.14
PEG	-8.59	0.28	-0.31
Price/Book	18.13	1.13	0.96
Price/Cash Flow	72.76	-16.92	9.79
Prices/Earnings	-14.14	11.10	12.93
Price/Sales	-25.13	6.52	8.70
Price/FCF	72.76	-16.92	9.79
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-7.62	0.92	1.00
Operating Margin	6.59	0.18	0.17
ROA	32.21	< 0.005	< 0.005
ROE	0.02	0.03	37.59
ROIC	< 0.005	< 0.005	18.47
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.35	-0.23	56.22
Dividends QOQ	0.07	-0.07	-3.86
EBIT QOQ	-0.48	0.64	33.24
EPS QOQ	-0.42	0.39	-6.08
FCF QOQ	0.17	-1.67	857.86
Revenue QOQ	-0.02	0.54	2855.55
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	-5804.29	-100.00
Days Sales Outstanding (DSO)	236.11	159.69	-32.37
Inventory Turnover	0.00	-0.02	-100.00
Debt/Capitalization	0.54	0.62	14.70
Quick Ratio	5.85	0.99	-83.08
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	51.30	50.83	-0.92
Cash	100.18	113.64	13.44
Capex	0.00	0.00	0.00
Free Cash Flow	5.03	-3.41	-32.25
Revenue	5.66	8.84	56.33
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.59	0.96	-39.60
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.60	-87.52	-3263.09
Naive Interpretation	Member

06 - Financial Health · Bad

Rating